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1. Introduction 
Detection and localization of hepatitis viruses in liver tissue are vital for diagnostic purposes 
and clinical management of infected patients, as well as for the elucidation of 
viropathological mechanisms. The fragility of RNA and/or the low levels of viral expression 
in infected tissues are a constant limitation in molecular assays for viral characterization. 
Viral antigen detection, by immunochemistry, in liver biopsies is an attractive option for 
precise localization and quantification of viral proteins with direct access to histological 
patterns. We will describe studies using immunohistochemical methods effective on fixed, 
archived specimens, including liver biopsies and surgical resection samples.  
1.1 Chronic hepatitis B 
Natural course of type B hepatitis is now well established and the different phases of the 
disease are clearly defined. Briefly, after contamination early in life, there is a first phase 
of immune tolerance. During this phase, the virus is highly replicative, HBV DNA, HBs and 
HBe antigen are at high level in the serum, but clinical, biological, and histological signs 
are more or less normal. These patients are highly contagious, and most of them are going 
to be HBV carriers for the rest of their life. This model if frequent in highly endemic 
countries where a high rate of mother-to-baby transmission exists (especially in Asia); 
This phase is absent when people are infected as adults, their immune system being 
mature. They present an acute hepatitis and only a few of them (10%) will remain carrier 
with chronic hepatitis B. The phase of tolerance lasts for about 15 to 20 years. Nowadays 
very few people are having liver biopsy during that period. When it was done in the 
70’s/80’s HBV antigens immunostaining were quite impressive: HBs antigen was present 
in a diffuse aspect grade associated with a strong expression for HBc antigen on more 
than 50% of nuclei (Table 1).  
During the second phase of the immune clearance phase, hepatitis activity increase with 
fluctuating high level of ALT, necrosis, inflammatory cells infiltrates, fibrosis and decrease 
HBV viraemia. This period of high activity is associated sometimes with severe hepatic failure. 
At the end of this phase occurs HBe seroconversion which is often associated with clinical 
remission. The expression of HBV antigens detected by immunostaining is varying according 
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to the time from infection when the biopsy was performed. The large number of HBs diffuse 
positive hepatocytes is decreasing with time. Many small clusters of cytoplasmic or sub 
membranous cells are gathering in the liver tissue the nuclear expression of HBc antigen is 
progressively changed in cytoplasmic expression and finally HBc antigen is undetectable. This 
stage corresponds to a very low viral replication (HBV DNA from 1000 UI/ml to null.). 
 
Phases of 








cytoplasmic   
Immune 




clearance 0 to +++ frequent emerging rare frequent emerging 
Inactive phase 
early period 0 to + rare frequent frequent unusual frequent 
Inactive phase 





Reactivation + to +++ frequent frequent frequent frequent frequent 
Table 1. Summary of the aspects and patterns of HBV antigen along the natural course of 
chronic type B hepatitis. 
During the third phase called the inactive carrier phase, clinical remission may occur earlier in 
life if infection had occurred in adulthood ; Usually liver biopsy is done at that period to 
graduate residual inflammatory activity and over all staging the fibrosis. HBs Ag can be 
detected by immunostaining : 
- on very few hepatocytes; this can be seen after a very long carriage of HBV; it is 
correlated with a low level of HBs antigen in the serum. 
- on very large clusters of cytoplasmic pattern including almost all the hepatocytes. These 
patients have a very high level of HBs antigen in serum, exclusively made of spherical 
and tubular empty particles. 
HBc antigen is usually undetectable. In very low replicative patients some cytoplamic 
expression can be detected in rare hepatocytes. 
During this inactive phase, reactivations may occur. If liver biopsy is done during this period, 
expression of viral antigens is similar to the clearance period, associated in many cases with 
intense expression of HBs antigen in the diffuse or cluster like pattern. If the patient is not 
treated for this reactivation, HBs antigen will decrease and HBc antigen will appear in some 
nuclei.  
1.2 Liver transplantation 
In the vast majority of the cases, histological examination is able to explain if a flare of 
activity (cytolysis) is associated with graft rejection or re-infection of the graft by HBV. In 
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case of re-infection, diffuse HBs antigen is weakly present in its cytoplasmic pattern and 
nuclear HBc is detected. 
1.3 Occult HBV hepatitis 
In some cases of occult hepatitis infection (HBV DNA detectable in the liver and possibly in 
the serum in the absence of the landmark of HBV infection, the HBsAg in the serum).  
In those cases, few hepatocytes may be weakly positive for either HBs or HBc antigen. It can 
be helpful for the diagnosis of these very peculiar forms of HBV infections. 
1.4 Hepatitis C hepatitis 
The Hepatitis C virus (HCV) genome is a single stranded RNA molecule of about 9500 bp. 
This RNA encodes for a large poly-protein that is processed by host and virus proteases into 
several structural and non structural viral proteins (Envelope, Capsid and NS2a/b NS3a/b 
NS4a/b NS5a/b respectively). The detection of HCV replicative intermediates or virus antigen 
may be helpful for diagnosis or clinical management of patients with HCV infection and it is of 
crucial importance for monitoring patients prior and post- HCV-related liver transplantation. 
In a general point of view, HCV replication level seems to be relatively low in infected liver, 
hampering the detection of HCV particles directly in the liver (Shimizu et al., 1996, Negro, 
1998). Detection methods based on HCV RNA amplification as in situ PCR or in situ 
hybridization are not completely efficient for HCV detection and can lead to conflicting results 
concerning viral particles localization (Lau et al., 1996). However they remain an interesting 
tool when used in complement of classical method (Biagini et al., 2001, Comar et al., 2006). 
Limitation of these methods is probably due to RNA rapid degradation in tissues and 
difficulty to design efficient probes to overcome high variability of HCV genomes.  
Detection of HCV antigens by immunochemistry in liver biopsies constitutes therefore an 
interesting option that allows both localization and quantification of viral proteins (Galy et 
al, 2006).  
2. Methods  
2.1 Hepatitis B antigens 
Slides are deparaffinized in methylcyclohexane (two baths for 10 minutes) then re-hydrated 
through 4 baths of ethanol and soaked for half an hour in PBS pH 7.2; and endogenous 
peroxidase blocked by H2O2. 
Slides are then incubated in a humid chamber for 30 minutes at room temperature with 
diluted anti-HBs antibody, and then rinsed 4 times in PBS pH 7.2. A second incubation in 
same conditions is made with the secondary antibody (anti rabbit or mouse 
immunoglobulin, according to the primary antibody) labelled with peroxydase. Commercial 
kit with DAB substrate (Dako USA) are used to develop the final reaction. 
Counterstaining with Harris haematoxylin is added on slides for HBs antigen search. 
Usually no counterstaining is performed on slides tested for HBc antigen as it might interact 
with the nuclear expression of this viral antigen. 
Reagents: 
- Anti-Hbs monoclonal mouse antibody Dako USA (clone 3E7) or Argene F( ref:11-086) 
- Polyclonal rabbit Anti –Hbc ready to use Dako USA 
- Antibody diluent Dako USA 
- Envision dual link kit Dako USA 
- Hematoxylin Biomedia USA 
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2.2 Hepatitis C antigen 
First tissue sections are deparaffinized in xylene for 10 minutes (twice). Then Rehydrate in 
graded ethanol concentrations (100% and 95% for 5 min each) and proceed immediately to 
Block endogenous peroxidase activities with incubation in methanol (0.3% hydrogen peroxide) 
for 30 minutes at room temperature. The unmasking procedure includes a microwave 
treatment. The slides are placed in microwave for 15min in antigen unmasking solution 
(Vector H3300 - Vector Laboratories, Burlingame, CA, USA). Keep slides to cool down for 30 
min in the same unmasking solution. Incubate with PBS solution (5% skimmed milk and 0,1% 
BSA) for 1 hour at room temperature. Sections are incubated overnight with the primary mAb 
(For D4.12.9: concentration 0.2µg/ml) at 4°C. Sections without primary antibody can be used as 
controls. Wash in PBS (3x5 min). Incubate 30 min with Secondary antibody at 5µl/ml (Elite 
Kit- Vector Laboratories, Burlingame, CA, USA) in PBS solution (0,1% BSA). Wash again in 
PBS (3x5 min). Amplify signal at 37°C for 45min with VECTASTAIN ABC Kit (Vector 
Laboratories, Burlingame, CA, USA) – Use 0,1%BSA PBS solution. Wash in PBS (3x5 
min).Incubate tissue sections with the DAB substrate (Vector kit SK 4100, Vector Laboratories, 
Burlingame, CA, USA) at room temperature for 5 minutes.Wash in PBS (3x5 min). 
Counterstain the sections with Mayer’s haematoxylin. Dehydrate through a successive ethanol 
baths (95% Ethanol, absolute ethanol and xylene -5 min in each solution). Mount slides using 
standard microscope cover glass and mounting medium. 
2.3 Hepatitis delta antigen 
Direct immunostaining in fluorescence may be used for delta antigen. Once deparaffinized 
as above, slides are at first incubated for 30 minutes with a solution of proteinase  
K(21 mg/ml in Tris EDTA buffer) then rinsed in PBS for 15 minutes . Incubation with the 
FITC labelled anti-delta antibody is performed in humid chamber for half an hour. Slides 
are rinsed in two baths of PBS for 15 minutes and mounted. 
Reagents: 
- Proteinase K recombinant Roche USA  
- Tris EDTA buffer Sigma Aldrich USA 
- Polyclonal rabbit anti delta antibody labelled with FITC is kindly provided by Dr Alan 
Kay INSERM unit 1052, Lyon, France. 
3. Examples of viral hepatitis antigens detection  
3.1 Hepatitis B  
3.1.1 Cytological patterns of HBs antigen 
Three different patterns are seen on liver biopsies: 
i. Cytoplasmic : this is the most common pattern , consisting in a large vacuole made of the 
Golgi reticulum full of viral envelopes. In light microscopy it is usually called “ground 
glass” hepatocytes. The intensity of the staining is closely correlated with the amount of 
viral envelope in the cell (Figure 1). 
ii. Submembranous : This pattern is not frequent ; it is associated with a strong production 
of viral envelope and might be a former stage of the cytoplasmic pattern (Figure 2). 
iii. Membranous: This is a less common pattern. It is often seen on a few hepatocytes; it is 
mostly associated with strong viral expression and is rather present in active 
periportal zone. Staining underlines the cell membrane in a perfect straight line. 
(Figure 3) 
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Fig. 1. Two typical ground glass hepatocytes stained with immunoperoxydase for HBs 
antigen.( magnification x 600) 
 
 
Fig. 2. Submembranous expression of HBs antigen in hepatocytes ( immunoproxydase 
magnification x 600). 
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Fig. 3. Membranous expression of HBs antigen: arrow shows the perfectly straight pattern of 
the cell membrane (immunoperoxydase magnification x 600). 
3.1.2 Cytological patterns of HBc antigen 
i. Nuclear: This is the most common expression pattern of this antigen in liver cells  
(Figure 4). 
ii. Cytoplasmic : The design is different from the HBs Antigen one as it is not gathered in a 
part of the cell but more or less diffuse in the whole cytoplasmic area (Figure 5). 
iii. In many cases, cells can express both of these patterns (Figure 6). 
 
 
Fig. 4. Nuclear expression of HBc antigen. Note the large scale of intensity of the staining 
(immunoproxydase, magnification x 600). 
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Fig. 5. Cytoplasmic expression of HBc antigen (immunoperoxydase, magnification x 600). 
 
 
Fig. 6. Double expression of HBc antigen: cytoplasmic and nuclear, sometimes in the same 
hepatocyte (immunoperoxydase magnification x 600). 
3.1.3 Antigen expression in liver tissue 
The antigen expression in liver tissue is important to observe as it correlates to the stage of 
replication and natural history of the disease. 
HBs antigen 
Two main patterns can be observed: 
i. Diffuse or dotted: Positive liver cells are non confluent, diffuse in the lobule. It can be 
useful to estimate the number of positive cells in the biopsy. This can be done semi 
quantitatively as an amount grade +, ++, +++ (Figures 7, 8, 9). 
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Fig. 7. Diffuse expression of cytoplasmic HBs antigen: amount grade: + , the only strong 
positive cell out of a 15 mm length needle biopsy (immunoperoxydase magnification x 100). 
 
 
Fig. 8. Diffuse expression of cytoplasmic HBs antigen in strongly stained hepatocytes, 
amount grade: ++ (immunoperoxydase magnification x 100) 
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Fig. 9. Diffuse expression of cytoplasmic HBs antigen, light staining, amount grade +++ 
(immunoperoxydase, magnification x 100) 
 
 
Fig. 10. Diffuse expression of cytoplasmic  HBs antigen, strong staining, amount grade +++ 
(immunoproxydase, magnification x 75). 
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ii. Confluent or cluster-like pattern: Positive cells are closely gathered inside the lobule can 
be detected on contiguous lobules (Figures 11, 12, 13). Sometimes, this pattern can be 
associated with the diffuse pattern on the external zone of the cluster (around the 
cluster). The distribution of these clusters of positive cells is not homogenous in the 
whole liver. False negative of the immunochemistry staining is possible if the needle 
doesn’t reach a positive zone (See Figure 12) with a strong contrast between positive 
and negative area on a surgical biopsy); 
 
 
Fig. 11. Large cluster of sub membranous HBs antigen positive hepatocytes 
(immunoperoxydase, magnification x 40). 
 
 
Fig. 12. Cluster of HBs antigen positive cells crossing a lobule from portal tract to Centro 
lobular vein. ( immunoperoxydase, magnification x 75 
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Fig. 13. Large cluster of HBs antigen positive hepatocytes with a cytoplasmic pattern. Note 
the strong contrast between positive and a very weak positive area (immunoproxydase, 
magnification x 40). 
Sub membranous and membranous pattern are always expressed in the liver tissue as a 
cluster like pattern (Figure 14) 
 
 
Fig. 14. Presence of three patterns of HBs antigen: 
top : sub membranous, centre: membranous and left: cytoplasmic. (immunoperoxydase, 
magnification x 40) 
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Fig. 15. Very weak expression of HBs antigen in a liver biopsy of an occult carrier of HBV 
(immunoperoxydase, magnification x 400). 
HBc antigen 
As the presence of HBc antigen in the liver is correlated with the amount of invective whole 
Dane particles, quantification is possible. For the nuclear pattern it is usual to calculate the 
percentage of positive cells in the biopsy. 
Five classes of percentage are described: less than 1%, from 1 to 5%, from 5 to 20%, from 20% 
to 50% and over 50%.  
The cyoplasmic pattern is more difficult to quantify as it might be very weakly expressed in 
some cells. We usually describe 4 classes: rare positive cells, positive +, positive ++, positive 
+++. 
3.2 Hepatitis C  
In our personal experience (Galy et al., 2006), the staining location for Anti-E2 
immunostaining is mainly cytoplasmic with occasional perimembranous staining 
(including cytoplasmic and nuclear membrane). Staining pattern is mainly coarse 
granular with microvesicular pattern (Figure 16 ). HCV staining patterns appears to differ 
slightly according to the pathological status of the liver tissue. We observed a very strong 
staining of hepatocyte membrane, cytoplasm and perinuclear regions in liver from patient 
with active HCV-related cirrhosis (Intense plasma and nuclear membrane staining was 
observed in cases with high inflammatory activity). In non-cirrhotic and non-tumoral 
tissues Anti-E2 staining intensity increases with hepatitis fibrosis state. In HCV-related 
tumors, staining was exclusively detected within regeneration nodules and confined to 
hepatocytes whose morphology remains unchanged. Staining pattern appeared with two 
distinct patterns: trabecular throughout the hepatic parenchyma or concerning isolated 
cells. 
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Fig. 16. Expression of HCV E2 antigen in a  liver biopsy of cirrhotic liver of an HCV chronic 
carriers. Arrows: Few remaining hepatocytes strongly positive with anti-E2 antibody. 
Immunoperoxydase magnification X 200 
3.3 Hepatitis delta 
Antigen delta is expressed mainly in the nucleus of the hepatocyte and in rare cases can also 
be expressed in the cytoplasm; it depends on the stage of the replication and the production 
of antigen. The nuclear expression seems to be more correlated with a period of stoking of 
viral core. The result of the test is qualitative: negative or positive (Figure 17). 
 
 
Fig. 17. Intranuclear expression of Delta (HDV) antigen. FITC labelling, magnification x 100 
4. Conclusion 
Concerning Hepatitis B virus (HBV) detection of HBs and HBc antigens are informative and 
provide different patterns providing elements in correlation with the natural history of HBV 
infection including viral load. In the specific case of occult HBV infection (HBV DNA 
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detected in the absence of HBsAg in the serum) it may help to confirm the diagnosis. For 
Hepatitis C virus (HCV) antigen detection it exists antibodies that are able to successfully 
detected HCV on paraffin-embedded sections from fresh as well as archived-frozen, 
material. It should be noted that HCV detection in archived serum may be problematic due 
to delicate extraction and stability of RNA and this is the same for hepatitis delta virus 
diagnosis (HDV). Thus, IHC represents a very stable diagnostic tool as compared to RNA-
based approaches. We found important differences in the localization of HCV between 
tumor and non-involved, adjacent tissue in HCC cases.  
These protocols offer easy, precise and strong staining resolution with distinct patterns 
consistent with the liver pathology, irrespective of the hepatitis viruses examined. This 
approach provides applications for diagnosis as well as for exploratory pathological studies. 
Thus, IHC to detect viral hepatitis antigens may have a number of important applications 
for clinical diagnostic, research on the mechanisms of pathogenesis of viral hepatitis-
containing lesions, and retrospective evaluation of the contribution of hepatitis viruses to 
liver diseases using archives of paraffin-embedded material not suitable for molecular 
analysis. 
5. Acknowledgements 
Thanks to Dr M. Chevallier , J.Y. Scoazec, B. Bancel and F. Berger who kindly provide us 
with liver sections. 
6. References 
[1] Shimizu, Y.K., et al., Hepatitis C virus: detection of intracellular virus particles by electron 
microscopy. Hepatology, 1996. 23(2): p. 205-9. 
[2] Negro, F., Detection of hepatitis C virus RNA in liver tissue: an overview. Ital J Gastroenterol 
Hepatol, 1998. 30(2): p. 205-10. 
[3] Lau, J.Y., et al., In situ detection of hepatitis C virus--a critical appraisal. J Hepatol, 1996. 24(2 
Suppl): p. 43-51. 
[4] Biagini, P., et al., Hepatitis C virus RNA detection by in situ RT-PCR in formalin-fixed 
paraffin-embedded liver tissue. Comparison with serum and tissue results. Cell Mol Biol 
(Noisy-le-grand), 2001. 47 Online Pub: p. OL167-71. 
[5] Comar, M., et al., HBV, HCV, and TTV detection by in situ polymerase chain reaction could 
reveal occult infection in hepatocellular carcinoma: comparison with blood markers. J Clin 
Pathol, 2006. 59(5): p. 526-9. 
[6] Galy, O., et al., Efficient hepatitis C antigen immunohistological staining in sections of normal, 
cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-
derived HCV E2 glycoproteins. Cancer Lett, 2006. 
www.intechopen.com
Liver Biopsy
Edited by Dr Hirokazu Takahashi
ISBN 978-953-307-644-7
Hard cover, 404 pages
Publisher InTech
Published online 06, September, 2011
Published in print edition September, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Liver biopsy is recommended as the gold standard method to determine diagnosis, fibrosis staging, prognosis
and therapeutic indications in patients with chronic liver disease. However, liver biopsy is an invasive
procedure with a risk of complications which can be serious. This book provides the management of the
complications in liver biopsy. Additionally, this book provides also the references for the new technology of liver
biopsy including the non-invasive elastography, imaging methods and blood panels which could be the
alternatives to liver biopsy. The non-invasive methods, especially the elastography, which is the new
procedure in hot topics, which were frequently reported in these years. In this book, the professionals of
elastography show the mechanism, availability and how to use this technology in a clinical field of
elastography. The comprehension of elastography could be a great help for better dealing and for
understanding of liver biopsy.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
P Chevallier-Queyron and I Chemin (2011). Immunostochimistry as a Tool for Chronic Hepatitis Diagnosis,
Liver Biopsy, Dr Hirokazu Takahashi (Ed.), ISBN: 978-953-307-644-7, InTech, Available from:
http://www.intechopen.com/books/liver-biopsy/immunostochimistry-as-a-tool-for-chronic-hepatitis-diagnosis
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
